Merck's $919 Million Trading Day Lands 97th as Stock Drops 0.81%

On July 21, 2025, Merck's trading volume reached $919 million, ranking 97th in the day's stock market. Merck's stock price fell by 0.81%, marking the third consecutive day of decline, with a total decrease of 3.79% over the past three days.

Merck has committed to using Veeva Vault CRM to support its commercial execution across various new therapeutic areas and modalities. This partnership aims to drive customer success and provide a technology foundation for Merck's launch period, which is one of the most significant in the company's history. The decision to adopt Veeva Vault CRM is part of a broader expansion of Merck's partnership with Veeva Systems, a leading provider of cloud software solutions for the life sciences industry. The Vault CRM solution is designed to drive effective commercial execution across both personal and digital channels, addressing the unique regional and country-specific business and compliance requirements of the pharmaceutical sector.

Dave Williams, executive vice president and chief information and digital officer at Merck, expressed enthusiasm for the partnership, stating that the move to Vault CRM will provide Merck with the technology foundation to drive commercial execution. Peter Gassner, CEO of Veeva Systems, noted that Merck has consistently been at the forefront of leading-edge science that improves the lives of millions around the world, and Veeva is honored to be a strategic partner to Merck.